Class II recall: Baxter Healthcare Corporation: Daptomycin, in 0.9% Sodium Chloride Injection, 500 mg per 50 mL (10 mg/mL), 500

Baxter Healthcare Corporation has issued a Class II recall for Daptomycin in 0.9% Sodium Chloride Injection, 500 mg per 50 mL (10 mg/mL), supplied as single dose containers in 24-bag cartons under NDC 0338-0714-24. The recall was initiated due to current Good Manufacturing Practice (cGMP) deviations, according to the recall notice.

Most relevant for: Hospitals and infusion settings using this specific lot of premixed daptomycin 500 mg/50 mL single dose bags for intravenous antibiotic therapy.

Summary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.

Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.